Patents by Inventor Mark Rubin
Mark Rubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240082177Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.Type: ApplicationFiled: November 10, 2023Publication date: March 14, 2024Applicants: MESHABERASE, LLC, The United States of America, as Represented by the Secretary, Department of Health & Human ServicesInventors: Benjamin Rubin, Mark Gilbert, Jinkyu Jung
-
Publication number: 20230397627Abstract: The present disclosure relates generally to the use of fat blends and emulsions of fat blends (such as water-in-oil fat blends) to improve certain features of a comestible product. In certain embodiments, certain water-in-oil emulsions disclosed herein can be suitably used to improve the organoleptic properties, the perceived texture, the perceived juiciness, or the mouthfeel of various foods, pet foods, or feed products, such as meat analogue products.Type: ApplicationFiled: December 20, 2021Publication date: December 14, 2023Applicant: Firmenich SAInventors: Howard MUNT, Philipp ERNI, Mark RUBIN, Robert WAGNER, Mirela PASCU
-
Publication number: 20220389523Abstract: In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.Type: ApplicationFiled: August 5, 2022Publication date: December 8, 2022Inventors: Francesca Demichelis, Karl Garsha, Phillip C. Miller, Ray B. Nagle, Michael Otter, Gary Anthony Pestano, Mark Rubin
-
Publication number: 20220329697Abstract: Systems and methods for determining if a service interruption is associated with a placed toll-free call and if so, routing future toll-free calls to an alternative carrier route to ensure that subsequently placed toll-free calls are connected with the toll-free subscriber.Type: ApplicationFiled: March 15, 2022Publication date: October 13, 2022Inventors: Nicholas W. Reifschneider, Brett A. Scorza, Mark Rubin
-
Patent number: 11441189Abstract: In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.Type: GrantFiled: April 12, 2018Date of Patent: September 13, 2022Assignees: Ventana Medical Systems, Inc., Cornell UniversityInventors: Francesca Demichelis, Karl Garsha, Phillip C. Miller, Ray B. Nagle, Michael Otter, Gary Anthony Pestano, Mark Rubin
-
Publication number: 20220167642Abstract: The present disclosure relates generally to fat blends, emulsions of fat blends (such as water-in-oil fat blends), and uses thereof. In certain embodiments, certain water-in-oil emulsions disclosed herein can be suitably used to improve the organoleptic properties, the perceived texture, the perceived juiciness, or the mouthfeel of various foods, pet foods, or feed products, such as meat analogue products. In certain aspects, the disclosure also relates to the use of the water-in-oil emulsion disclosed herein as a partial or full replacement of animal in various foods, pet foods, or feed products. In certain aspects, the disclosure also relates to methods of preparing water-in-oil emulsions and various food products comprising such water-in-oil emulsion.Type: ApplicationFiled: June 26, 2020Publication date: June 2, 2022Applicant: Firmenich SAInventors: Philipp ERNI, Mark RUBIN, Howard MUNT, Robert WAGNER, Mirela PASCU
-
Patent number: 11247048Abstract: A gait modulation system including: (a) a sensor device including a sensor adapted for associating with at least one lower limb of the patient, the sensor for transducing at least one parameter related to a gait of the patient, so as to obtain gait data related to the gait, and (b) a muscle stimulator including: (i) an electrical stimulation circuit, the circuit adapted to supply an electrical stimulation output to an electrode array for performing functional electrical stimulation of at least one muscle of the lower limb, and (ii) a microprocessor, operatively connected to the at least one sensor, the microprocessor adapted for: receiving a stream of gait information based on the gait data; processing the gait information, and controlling the stimulation output based on the processing of the gait information, and wherein the microprocessor is further adapted to identify a failure in the stream of gait information, and to consequently control the electrical stimulation circuit to deliver a fail-safe stimulatiType: GrantFiled: January 27, 2020Date of Patent: February 15, 2022Assignee: Bioness Neuromodulation Ltd.Inventors: Eyal Lasko, Shmuel Springer, Mark Rubin, Amit Dar
-
Publication number: 20200234307Abstract: The present disclosure relates to systems, methods, and computer readable media for detecting periodic sequences of events. A computer-implemented method may include collecting processing times and values associated with each of a plurality of events. The method may also include assigning each of the plurality of events to at least one of a plurality of time phases, the plurality of time phases forming a period characteristic of the plurality of events. The method may also include grouping the events in each of the plurality of time phases into one or more clusters, based on the respective values associated with the events. The method may also include determining a periodic sequence of events based on the one or more clusters. The method may further include recording the periodic sequence of events in a database of periodic sequences.Type: ApplicationFiled: March 18, 2020Publication date: July 23, 2020Applicant: FIS Financial Compliance Solutions, LLCInventors: Mark A. Rubin, Stanley Tam, Minghai Li
-
Patent number: 10685072Abstract: An Internet or other online service is personalized or customized based on data collected for a user of a computing device. In one embodiment, a method includes: storing a plurality of person profiles for persons associated with communications received by a user of a computing device; receiving data associated with an online service; and filtering, using at least one processor, the data based on the plurality of person profiles, wherein the filtered data is for display to the user on the computing device.Type: GrantFiled: February 7, 2017Date of Patent: June 16, 2020Assignee: OATH INC.Inventors: Mark Rubin, Brian Hein
-
Patent number: 10668381Abstract: A system and method are provided for transparently styling non-player characters (“NPCs”) in multiplayer video games such that it is difficult to distinguish between human players and computer-controlled NPCs. NPCs may be styled to resemble human players in terms of both player profile attributes and gameplay actions such that players may not recognize NPCs as non-human, computer-controlled players. Additionally, or alternatively, NPCs and/or human players may be presented with a limited set of profile attributes that may reduce or eliminate the ability to distinguish between human players and NPCs, one or more profile attributes may be “anonymized,” and/or the ability to view player profiles of human players and/or NPCs may be disabled altogether. In certain gameplay sessions including real and/or practice gameplay sessions, human players may be prompted to select from among a predetermined set of playable characters having predefined profile attributes.Type: GrantFiled: September 25, 2018Date of Patent: June 2, 2020Assignee: Activision Publishing, Inc.Inventors: Michael Condrey, Mark Rubin
-
Publication number: 20200155842Abstract: A gait modulation system including: (a) a sensor device including a sensor adapted for associating with at least one lower limb of the patient, the sensor for transducing at least one parameter related to a gait of the patient, so as to obtain gait data related to the gait, and (b) a muscle stimulator including: (i) an electrical stimulation circuit, the circuit adapted to supply an electrical stimulation output to an electrode array for performing functional electrical stimulation of at least one muscle of the lower limb, and (ii) a microprocessor, operatively connected to the at least one sensor, the microprocessor adapted for: receiving a stream of gait information based on the gait data; processing the gait information, and controlling the stimulation output based on the processing of the gait information, and wherein the microprocessor is further adapted to identify a failure in the stream of gait information, and to consequently control the electrical stimulation circuit to deliver a fail-safe stimulatiType: ApplicationFiled: January 27, 2020Publication date: May 21, 2020Applicant: Bioness Neuromodulation Ltd.Inventors: Eyal LASKO, Shmuel SPRINGER, Mark RUBIN, Amit DAR
-
Patent number: 10543365Abstract: A gait modulation system including: (a) a sensor device including a sensor adapted for associating with at least one lower limb of the patient, the sensor for transducing at least one parameter related to a gait of the patient, so as to obtain gait data related to the gait, and (b) a muscle stimulator including: (i) an electrical stimulation circuit, the circuit adapted to supply an electrical stimulation output to an electrode array for performing functional electrical stimulation of at least one muscle of the lower limb, and (ii) a microprocessor, operatively connected to the at least one sensor, the microprocessor adapted for: receiving a stream of gait information based on the gait data; processing the gait information, and controlling the stimulation output based on the processing of the gait information, and wherein the microprocessor is further adapted to identify a failure in the stream of gait information, and to consequently control the electrical stimulation circuit to deliver a fail-safe stimulatiType: GrantFiled: July 9, 2018Date of Patent: January 28, 2020Assignee: Bioness Neuromodulation Ltd.Inventors: Eyal Lasko, Shmuel Springer, Mark Rubin, Amit Dar
-
Patent number: 10445716Abstract: Activation of a payment instrument via an interaction with a payment reader is described herein. A request for a payment instrument that is to be associated with an account of the merchant that is maintained in a ledger of a payment processing service can be received from a point-of-sale (POS) application associated with a merchant device of a merchant. The merchant device can receive a request to activate the payment instrument and can prompt the merchant to cause an interaction between the payment instrument and a payment reader associated with the merchant device. Payment data associated with the payment instrument can be received from the payment reader, and it can be determined that the payment data corresponds to known payment data associated with the payment instrument. Accordingly, the payment instrument can be activated to enable the merchant to use the payment instrument for accessing the account.Type: GrantFiled: September 28, 2018Date of Patent: October 15, 2019Assignee: Square, Inc.Inventors: Christina Riechers, Zachary Margolis, Michael Cormier, Bora Fezga, Clay Robbins, Mark Rubin, Swapnil Chavan
-
Patent number: 10443102Abstract: The invention relates generally to new prostate cancer markers, and particularly to a class of cancer marked by the presence of missense mutations in SPOP, an E3 ubiquitin ligase component. The invention provides methods and materials for detecting and diagnosing prostate cancer by detecting these mutations and may be useful in predicting disease progression and response to therapy.Type: GrantFiled: February 9, 2012Date of Patent: October 15, 2019Assignee: Cornell UniversityInventors: Mark A. Rubin, Christopher Barbieri
-
Publication number: 20190291007Abstract: A system and method are provided for transparently styling non-player characters (“NPCs”) in multiplayer video games such that it is difficult to distinguish between human players and computer-controlled NPCs. NPCs may be styled to resemble human players in terms of both player profile attributes and gameplay actions such that players may not recognize NPCs as non-human, computer-controlled players. Additionally, or alternatively, NPCs and/or human players may be presented with a limited set of profile attributes that may reduce or eliminate the ability to distinguish between human players and NPCs, one or more profile attributes may be “anonymized,” and/or the ability to view player profiles of human players and/or NPCs may be disabled altogether. In certain gameplay sessions including real and/or practice gameplay sessions, human players may be prompted to select from among a predetermined set of playable characters having predefined profile attributes.Type: ApplicationFiled: September 25, 2018Publication date: September 26, 2019Inventors: Michael Condrey, Mark Rubin
-
Patent number: 10294476Abstract: This invention relates to diagnosis and prognosis of prostate cancer, as well as therapeutic treatment of prostate cancer. More specifically, the invention provides diagnostic and prognostic methods based on detecting nuclear enriched abundant transcript 1 (NEAT1) levels in a sample. Further provided are methods for treating prostate cancer based on targeting NEAT1 via interfering RNA.Type: GrantFiled: April 17, 2015Date of Patent: May 21, 2019Assignee: CORNELL UNIVERSITYInventors: Dimple Chakravarty, Mark A. Rubin
-
Publication number: 20190114640Abstract: The present disclosure relates to systems, methods, and computer readable media for detecting periodic sequences of events. A computer-implemented method may include collecting processing times and values associated with each of a plurality of events. The method may also include assigning each of the plurality of events to at least one of a plurality of time phases, the plurality of time phases forming a period characteristic of the plurality of events. The method may also include grouping the events in each of the plurality of time phases into one or more clusters, based on the respective values associated with the events. The method may also include determining a periodic sequence of events based on the one or more clusters. The method may further include recording the periodic sequence of events in a database of periodic sequences.Type: ApplicationFiled: October 18, 2018Publication date: April 18, 2019Applicant: FIS Financial Compliance Solutions, LLCInventors: MARK A. RUBIN, Stanley Tam, Minghai Li
-
Patent number: 10190173Abstract: Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.Type: GrantFiled: May 9, 2016Date of Patent: January 29, 2019Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, THE BRIGHAM AND WOMEN'S HOSPITAL, INC.Inventors: Scott Tomlins, Daniel Rhodes, Arul Chinnaiyan, Rohit Mehra, Mark A. Rubin, Xiao-Wei Sun, Sven Perner, Charles Lee, Francesca Demichelis
-
Publication number: 20190009086Abstract: A gait modulation system including: (a) a sensor device including a sensor adapted for associating with at least one lower limb of the patient, the sensor for transducing at least one parameter related to a gait of the patient, so as to obtain gait data related to the gait, and (b) a muscle stimulator including: (i) an electrical stimulation circuit, the circuit adapted to supply an electrical stimulation output to an electrode array for performing functional electrical stimulation of at least one muscle of the lower limb, and (ii) a microprocessor, operatively connected to the at least one sensor, the microprocessor adapted for: receiving a stream of gait information based on the gait data; processing the gait information, and controlling the stimulation output based on the processing of the gait information, and wherein the microprocessor is further adapted to identify a failure in the stream of gait information, and to consequently control the electrical stimulation circuit to deliver a fail-safe stimulatiType: ApplicationFiled: July 9, 2018Publication date: January 10, 2019Applicant: Bioness Neuromodulation Ltd.Inventors: Eyal LASKO, Shmuel SPRINGER, Mark RUBIN, Amit DAR
-
Patent number: 10118099Abstract: A system and method are provided for transparently styling non-player characters (“NPCs”) in multiplayer video games such that it is difficult to distinguish between human players and computer-controlled NPCs. NPCs may be styled to resemble human players in terms of both player profile attributes and gameplay actions such that players may not recognize NPCs as non-human, computer-controlled players. Additionally, or alternatively, NPCs and/or human players may be presented with a limited set of profile attributes that may reduce or eliminate the ability to distinguish between human players and NPCs, one or more profile attributes may be “anonymized,” and/or the ability to view player profiles of human players and/or NPCs may be disabled altogether. In certain gameplay sessions including real and/or practice gameplay sessions, human players may be prompted to select from among a predetermined set of playable characters having predefined profile attributes.Type: GrantFiled: December 16, 2014Date of Patent: November 6, 2018Assignee: ACTIVISION PUBLISHING, INC.Inventors: Michael Condrey, Mark Rubin